Atlas Venture, the Cambridge, Mass.-based early-stage, biotech-focused venture firm, has for the first time raised an opportunity fund designed to help it support its most promising, maturing portfolio companies. The $250 million fund, announced by the firm this morning, is pretty well-timed, as these things go. Though the public markets have bounced back a bit […]
View More As market shifts, Atlas Venture closes a $250 million fund to support its breakaway biotech betsCategory: Atlas Venture
Boston-area startups are on pace to overtake NYC venture totals
Boston has regained its longstanding place as the second-largest U.S. startup funding hub. After years of trailing New York City in total annual venture investment, Massachusetts is taking the lead in 2018.
View More Boston-area startups are on pace to overtake NYC venture totals